Nuvalent Inc Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NUVL | BPMC | CYTK | ||
| Company | Nuvalent Inc Cl A | Blueprint Medicines Corp | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 91.44 | 94.98 | 50.33 | ||
| High | 94.58 | 98.13 | 50.45 | ||
| Low | 90.11 | 92.97 | 47.56 | ||
| Last | 92.73 | 96.62 | 47.67 | ||
| Change | +1.56 | +1.81 | -2.19 | ||
| % Change | +1.71% | +1.91% | -4.39% | ||
| Volume | 396,800 | 778,900 | 1,822,900 | ||
| 20-Day Average Volume | 468,330 | 746,365 | 1,327,850 | ||
| Previous Close | 91.17 | 94.81 | 49.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 91.14 | 93.06 | 52.94 | ||
| 20-Day Raw Stochastic | 66.70% | 69.70% | 0.93% | ||
| 20-Day Relative Strength | 49.27% | 55.93% | 37.74% | ||
| Weighted Alpha | +36.36 | +29.11 | -19.49 | ||
| Today's Opinion | 56% Buy | 16% Sell | 100% Sell | ||
| Previous Opinion | 40% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 64% Buy | 88% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.83% since 11/14/24 | +1.01% since 11/14/24 | -12.85% since 11/14/24 | ||
| Low | 85.38 on 11/18/24 | 88.05 on 11/18/24 | 47.56 on 11/21/24 | ||
| High | 94.58 on 11/21/24 | 98.13 on 11/21/24 | 55.14 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -8.34% since 10/21/24 | +12.86% since 10/21/24 | -11.41% since 10/21/24 | ||
| Low | 85.38 on 11/18/24 | 80.68 on 10/29/24 | 47.56 on 11/21/24 | ||
| High | 103.62 on 10/22/24 | 103.55 on 11/11/24 | 59.39 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +12.18% since 08/21/24 | +1.94% since 08/21/24 | -15.75% since 08/21/24 | ||
| Low | 80.80 on 09/12/24 | 80.68 on 10/29/24 | 47.56 on 11/21/24 | ||
| High | 113.51 on 09/16/24 | 103.55 on 11/11/24 | 59.39 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +32.98% since 05/21/24 | -6.76% since 05/21/24 | -20.73% since 05/21/24 | ||
| Low | 64.26 on 05/31/24 | 80.68 on 10/29/24 | 46.25 on 05/28/24 | ||
| High | 113.51 on 09/16/24 | 121.90 on 07/16/24 | 61.38 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,907,633 | 6,022,900 | 5,884,178 | ||
| Shares Outstanding, K | 64,798 | 63,526 | 118,014 | ||
| Annual Sales | 0 | 249,380,000 | 7,530,000 | ||
| Annual Net Income | -126,220,000 | -506,980,000 | -526,240,000 | ||
| Last Quarter Sales | 0 | 128,180,000 | 460,000 | ||
| Last Quarter Net Income | -84,350,000 | -56,280,000 | -160,550,000 | ||
| 60-Month Beta | 1.33 | 0.59 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.28 on 11/12/24 | -0.89 on 10/30/24 | -1.36 on 11/06/24 | ||
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||